Skip to main content

Table 2 Baseline neuropsychological test scores

From: Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease

Variable (n = 641)

Average score

Range

MMSE

19.5 (6.64)

0-30

ADAS-Cog

24.3 (12.43)

1-68

BPMSE

19.6 (5.96)

0-25

CDR-SB

6.7 (4.02)

0.5-18

IADL

15.5 (6.50)

2-31

PSMS

7.9 (3.05)

6-25

  1. For all continuous variables, values are presented as mean (standard deviation). ADAS-Cog, Alzheimer's Disease Assessment Scale-Cognitive Subscale; BPMSE, Baylor Profound Mental Status Examination; CDR-SB, Clinical Dementia Rating-Sum of Boxes; IADL, Instrumental Activities of Daily Living; MMSE, Mini-Mental State Examination; PSMS, Physical Self-Maintenance Scale.